Results 71 to 80 of about 949,682 (362)

Detecting FR‐⍺ Expression Level in Cytology Effusion Specimens From Ovarian Cancer and Comparing It With Tissue Specimens

open access: yesDiagnostic Cytopathology, EarlyView.
ABSTRACT Background Folate receptor‐⍺ (FR‐⍺) is an attractive target for targeted therapy. Mirvetuximab soravtansine (MIRV) has been approved by the United States Food and Drug Administration (FDA) for treating adult patients with FR‐⍺ positive, platinum‐resistant epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Therefore,
Yadan Ma   +5 more
wiley   +1 more source

Fallopian tube origin of supposed ovarian high-grade serous carcinomas

open access: yesClinics, 2011
INTRODUCTION: Serous carcinomas are the most frequent histologic type of ovarian and peritoneal cancers, and can also be detected in the endometrium and fallopian tubes.
Patricia Martini Diniz   +3 more
doaj  

Comparison of Immediate and Delayed Transfer of Micro- Injected Oocytes into Fallopian Tubes: A Prospective, Randomized Clinical Trial [PDF]

open access: yesInternational Journal of Fertility and Sterility, 2008
Background Transfer of micro-Injected oocytes into fallopian tubes is an alternative procedure for IVF-ET with a similar success rate. This could be either done immediately after ovum pick-up microinjected oocytes intrafallopian transfer (MIFT) or after ...
Ashraf Alleyassin   +4 more
doaj   +1 more source

Torsion of fallopian tube, fimbrial cyst [PDF]

open access: yes, 2008
A case of fallopian tube fimbrial cyst torsion with haemorrhage is presented, occurring in a 37-year-old female who had tubal ligation 6 years back. She presented in emergency with acute abdomen.
Khan, Nadir, Masroor, Imrana
core   +1 more source

Detecting TP53 mutations in paired liquid and tissue biopsies from patients with high‐grade serous ovarian carcinoma

open access: yesInternational Journal of Cancer, EarlyView.
What's New? High‐grade serous ovarian carcinoma is often diagnosed at advanced stages due to non‐specific symptoms and the lack of reliable screening methods. This proof‐of‐concept study introduces a novel TP53 mutation panel using unique molecular identifier‐based next‐generation sequencing for sensitive detection of high‐grade serous ovarian ...
Amanda Olsson Widjaja   +11 more
wiley   +1 more source

Histomorphology of fallopian tubes in ectopic pregnancy

open access: yesArchives of Medicine and Health Sciences, 2016
Background: Ectopic pregnancy can present as an acute life-threatening emergency when it ruptures and accounts for about 10% of all maternal mortalities. The fallopian tube is the most common site for ectopic pregnancy (90–95%).
Savithri Ravindra   +2 more
doaj   +1 more source

Inflammation targets specific organs for cancer in carriers of BRCA1/2 pathway mutations [PDF]

open access: yes, 2010
Women who inherit a defective BRCA1 or BRCA2 gene have risks for breast/ovarian cancer that are so high and apparently so selective that many mutation carriers choose to have the most likely targets for cancer surgically removed.
Bernard Friedenson
core   +1 more source

The cervico‐vaginal DNA methylation WID‐qEC test: An epigenetic marker associated with ovarian cancer in the absence of endometrial and cervical cancer

open access: yesInternational Journal of Cancer, EarlyView.
What's New? The DNA methylation‐based WID‐qEC test has been validated for the accurate detection of endometrial and cervical cancers using cervico‐vaginal samples. However, a small proportion of women test positive despite the absence of these cancers. This study explored the associated biological and clinical characteristics to inform potential follow‐
Elisa Redl   +18 more
wiley   +1 more source

Persistent mullerian duct syndrome

open access: yesIndian Journal of Radiology and Imaging, 2010
Persistent Mullerian duct syndrome (PMDS) is a rare form of internal male pseudohermaphroditism in which Mullerian duct derivatives are seen in a male patient. This syndrome is characterized by the persistence of Mullerian duct derivatives (i.e.
Divya Renu, B Ganesh Rao, K Ranganath
doaj   +3 more sources

Home - About - Disclaimer - Privacy